Boyd’s OccluRad Wins BioPort Event
Daniel Boyd and ABK Biomedical yesterday won the $30,000 BioInnovation Challenge presented by BioNova for its development of OccluRad particles in the treatment of fibroid tumors.
BioNova, the umbrella group for the Nova Scotian biotech industry, initiated the BioInnovation Challenge this year in conjunction with the BioPort 2011 conference to encourage commercialization of research at the province’s universities.
ABK Biomedical is commercializing a method to improve recent innovations in the treatment of benign tumors in women by making the process simpler, safer and cheaper.
About